HIGHLIGHTS
SUMMARY
Determining an IL6 increase in COVID-19 patients have not been well established yet and the association over time between SARSCoV-2 viremia and IL6, has not been assessed in a prospective cohort with serial samples. Considering the previous results, the aim of this study was to evaluate the relationship between the presence of SARS-CoV-2 viremia and the time evolution and IL6 levels in a prospective cohort of COVID-19 hospitalized patients. A proteomic analysis showed that the expression of viral response and interferon/monocytic pathway proteins such as IL6 and one . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.